HC Wainwright Raises Arrowhead Pharmaceuticals Buy Rating to $85 from $80.

martes, 2 de diciembre de 2025, 7:32 am ET1 min de lectura
ARWR--

HC Wainwright Raises Arrowhead Pharmaceuticals Buy Rating to $85 from $80.

HC Wainwright Raises Arrowhead Pharmaceuticals Buy Rating to $85 from $80.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios